EyePoint Pharmaceuticals Inc (EYPT)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$5.98
Buy
$6.18
$-0.09 (-1.45%)
Prices updated at 20 Mar 2025, 22:05 EDT
| Prices minimum 15 mins delay
Prices in USD
EyePoint Pharmaceuticals Inc, formerly pSivida Corp develops tiny, sustained-release, drug delivery products designed to deliver drugs at a controlled and steady rate for months or years.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 91.42 |
| 2023 | 89.93 |
| 2022 | 79.89 |
| 2021 | 77.86 |
| 2020 | 83.09 |
| 2019 | 86.81 |
| 2018 | 100.00 |
| 2017 | 100.00 |
| 2016 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 7.94 |
| 2024 | 8.26 |
| 2023 | 20.48 |
| 2022 | 2.98 |
| 2021 | 9.11 |
| 2020 | 2.18 |
| 2019 | 22.98 |
| 2018 | 34.05 |
| 2017 | 5.18 |
| 2016 | 39.21 |
| 2015 | 84.56 |
Price/Forward earnings (YTD)
-2.17
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -33.83 |
| 2023 | -26.44 |
| 2022 | -46.09 |
| 2021 | -32.90 |
| 2020 | -55.13 |
| 2019 | -75.15 |
| 2018 | -117.70 |
| 2017 | -73.50 |
| 2016 | -67.35 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.24 |
| 2023 | 1.33 |
| 2022 | 1.87 |
| 2021 | 1.43 |
| 2020 | 4.95 |
| 2019 | 8.76 |
| 2018 | 6.13 |
| 2017 | 1.40 |
| 2016 | 1.51 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
